Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Abb Vie Inc. Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $91.1 Billion
- Q4 2024
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Abb Vie Inc. stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 1,370,400 shares of ABBV stock, worth $277 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
1,370,400
Previous 5,513,055
75.14%
Holding current value
$277 Million
Previous $1.09 Billion
77.63%
% of portfolio
0.27%
Previous 1.15%
Shares
34 transactions
Others Institutions Holding ABBV
# of Institutions
4,095Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$35 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.6 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$16.1 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10.5 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$8.02 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $357B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...